Literature DB >> 16520883

Incidence of schizophrenia does not vary with economic status of the country: evidence from a systematic review.

Sukanta Saha1, Joy Welham, David Chant, John McGrath.   

Abstract

BACKGROUND: A recent systematic review found that the prevalence of schizophrenia was lower in developing nations compared to developed nations. However, there is a lack of information about the association between economic status and the incidence of schizophrenia. The aim of this study was to examine the association between economic status and the underlying incidence of schizophrenia based on a recently published systematic review of the incidence of schizophrenia.
METHODS: The analyses were based on 167 discrete incidence rates from 52 studies. Nations were divided into three categories according to per capita gross national product. Based on these categories, we compared the incidence rates for schizophrenia when adjusted for within-study variation.
RESULTS: The median (and 10-90% quantiles) incidence rates per 100,000 persons for Least Developed Countries (three studies), Emerging Economies (nine studies), and Developed Countries (42 studies) were 20.0 (0.4-35.0), 11.0 (5.0-26.0) and 16.0 (8.0-48.0) respectively. There was no significant difference in incidence rates between these groups.
CONCLUSIONS: While there is a lack of information on the incidence of schizophrenia in the developing world, there is no evidence to suggest that the incidence of schizophrenia varies by economic status. In light of the evidence that the prevalence of schizophrenia is higher in developed countries, more research is warranted focused on the interaction between economic measures, and the incidence, prevalence and course of schizophrenia.

Entities:  

Mesh:

Year:  2006        PMID: 16520883     DOI: 10.1007/s00127-006-0041-7

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  4 in total

1.  Conducting psychiatric research in the developing world: challenges and rewards.

Authors:  Atalay Alem; Derege Kebede
Journal:  Br J Psychiatry       Date:  2003-03       Impact factor: 9.319

2.  Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study.

Authors:  A Jablensky; N Sartorius; G Ernberg; M Anker; A Korten; J E Cooper; R Day; A Bertelsen
Journal:  Psychol Med Monogr Suppl       Date:  1992

Review 3.  A systematic review of the prevalence of schizophrenia.

Authors:  Sukanta Saha; David Chant; Joy Welham; John McGrath
Journal:  PLoS Med       Date:  2005-05-31       Impact factor: 11.069

Review 4.  A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology.

Authors:  John McGrath; Sukanta Saha; Joy Welham; Ossama El Saadi; Clare MacCauley; David Chant
Journal:  BMC Med       Date:  2004-04-28       Impact factor: 8.775

  4 in total
  6 in total

1.  Incidence of hospitalised schizophrenia in Finland since 1980: decreasing and increasing again.

Authors:  Raimo K R Salokangas; Mika Helminen; Anna-Maija Koivisto; Helena Rantanen; Hannu Oja; Sami Pirkola; Kristian Wahlbeck; Matti Joukamaa
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-03-20       Impact factor: 4.328

2.  Dissecting the heterogeneity of schizophrenia outcomes.

Authors:  John McGrath
Journal:  Schizophr Bull       Date:  2007-11-28       Impact factor: 9.306

3.  Adding insult to injury: childhood and adolescent risk factors for psychosis predict lower fractional anisotropy in the superior longitudinal fasciculus in healthy adults.

Authors:  Pamela DeRosse; Toshikazu Ikuta; Bart D Peters; Katherine H Karlsgodt; Philip R Szeszko; Anil K Malhotra
Journal:  Psychiatry Res       Date:  2014-09-16       Impact factor: 3.222

Review 4.  Income inequality and schizophrenia: increased schizophrenia incidence in countries with high levels of income inequality.

Authors:  Jonathan K Burns; Andrew Tomita; Amy S Kapadia
Journal:  Int J Soc Psychiatry       Date:  2013-04-16

5.  Psychopharmacology of schizophrenia: The Future Looks Bleak.

Authors:  Chittaranjan Andrade; Rajiv Radhakrishnan; Praveen P Fernandes
Journal:  Mens Sana Monogr       Date:  2012-01

6.  Schizophrenia and Hospital Admissions for Cardiovascular Events in a Large Population: The APNA Study.

Authors:  Sara Guillen-Aguinaga; Antonio Brugos-Larumbe; Laura Guillen-Aguinaga; Felipe Ortuño; Francisco Guillen-Grima; Luis Forga; Ines Aguinaga-Ontoso
Journal:  J Cardiovasc Dev Dis       Date:  2022-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.